HLA class ii markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis

Tissue Antigens

Volumn 59, Issue 5, 2002, Pages 381-387

  Wassmuth, R ^a   Depner, F ^a   Danielsson, A ^b   Hultcrantz, R ^c   Loof L ^d   Olson, R ^e   Prytz, H ^f   Sandberg Gertzen, H ^g   Wallerstedt, S ^h   Lindgren, S ^a,i,j  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^h University Hospital   (Sweden)

ⁱ NONE   (Sweden)

^j LUND UNIVERSITY   (Sweden)

more..

Author keywords

Histocompatibitity antigens; HLA class II antigens; Liver disease; Primary biliary cirrhosis

Indexed keywords

HISTOCOMPATIBILITY ANTIGEN; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOGENETICS; LIVER DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MATHEMATICAL MODEL; ONSET AGE; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; AGED; BILIARY CIRRHOSIS; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; RISK FACTOR; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SWEDEN; HUMANS; MIDDLE AGED;

EID: 0036024561     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2002.590504.x     Document Type: Article

References (40)

1. Primary biliary cirrhosis
2. Primary biliary cirrhosis: Natural history
3. Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study
4. Primary biliary cirrhosis: New therapeutic directions
5. Immunointervention in primary biliary cirrhosis: An overview
6. Familial primary biliary cirrhosis
7. Genetic factors in primary biliary cirrhosis
8. DNA polymorphism of HLA class II genes in primary biliary cirrhosis
9. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype
10. Primary biliary cirrhosis: Contribution of HLA class II allele DR8
11. Major histocompatibility complex class-II alleles in primary biliary cirrhosis
12. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis
13. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis
14. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC)
15. Analysis of HLA class II encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis
16. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis
17. HLA DRw8 primary biliary cirrhosis
18. Cancer risk in primary biliary cirrhosis: A population-based study from Sweden
19. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
20. HLA DPB1 alleles provide protection against Crohn's disease in Caucasians
21. Non-radioactive oligotyping for HLA-DR1-DRw10 using polymerase chain reaction, digoxigenin-labelled oligonucleotides and chemiluminescence detection
22. Application of HLA-DR oligotyping to 110 kidney transplant patients with doubtful serological typing
23. Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes
24. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA
25. Analysis of isotypic and allotypic variation in the HLA-DRβ region using in vitro enzymatic amplification of specific DNA segments
26. Estimability and estimation in case-referent studies
27. On estimating the relation between blood group and disease
28. The estimated significance of the logarithm of a ratio of frequencies
29. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease
30. Primary biliary cirrhosis: Associations with class II major histocompatibility complex antigens
31. Association of primary biliary cirrhosis with the allele HLA- DPB1*0301 in a German population
32. Homozygosity for the HLA-DRB1 allele selects for extra-articular manifestations in rheumatoid arthritis
33. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
34. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
35. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis
36. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis
37. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex
38. Analysis of rearranged T cell receptor (TCR) V beta transcripts in livers of primary biliary cirrhosis: Preferential V beta usage suggests antigen-driven selection